Ascertainment of patients with myelodysplastic syndromes

Journal of Clinical Oncology

Volumn 29, Issue 1, 2011, Pages

  Ma, Xiaomei ^a   Wang, Rong ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTERNATIONAL CLASSIFICATION OF DISEASES; LETTER; LYMPHOPROLIFERATIVE DISEASE; MEDICARE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; UNITED STATES;

AGED; HUMANS; MYELODYSPLASTIC SYNDROMES; UNITED STATES;

EID: 79951980362     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.8287     Document Type: Letter

References (3)

1. Goldberg SL, Chen E, Corral M, et al: Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol 28:2847-2852, 2010
2. Ma X, Does M, Raza A, et al: Myelodysplastic syndromes: Incidence and survival in the United States. Cancer 109:1536-1542, 2007 (Pubitemid 46595689)
3. Rollison DE, Howlader N, Smith MT, et al: Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 112:45-52, 2008